RegeneRx Biopharmaceuticals Inc (OTCMKTS:RGRX) Stock Continues to Move in a Range

December 20, 2021

This past Friday, the RegeneRx Biopharmaceuticals Inc (OTCMKTS:RGRX) stock was trading in a range despite the fact that the company had made a significant announcement. However, at the same time, it ought to be noted that such stocks can also break out strongly and hence, it may be a good move to keep an eye on the stock today. Trading Data On Friday, RGRX stock fell by 1.94% to $0.1520…

Read More >>

RegeneRx Biopharmaceuticals Inc (OTCMKTS:RGRX) Stock Resumes Another Round Of Sell-Off

October 7, 2021

Clinical stage medicine developer RegeneRx Biopharmaceuticals Inc (OTCMKTS:RGRX), which is primarily concerned with tissue protection and repair products, saw its stock take a beating on Wednesday. The stock tanked by as much as 7% yesterday after the company announced the results from an independent research paper which indentified Thymosin Beta 4 or TB4 as a possible treatment for critical kidney injuries and for possibly reducing the mortality among patients who…

Read More >>